Market World Carcinoembryonic Antigen Market | Page 3

America will witness significant growth in the market owning to the factors such as increase alcohol
consumption, excessive smoking, and changing lifestyles.
Competitive Insights
The global carcinoembryonic antigen market is consolidated in nature with extensive mergers and acquisitions.
In 2017, Aviva Systems Corporation (ASB), a protein solutions and application provider is offering products for
both research and diagnostic market acquired GenWay Biotech, Inc. Some of the key players in this market
include F. Hoffmann-La Roche Ltd; GenWay Biotech, Inc.; Abbott; Correlogic Systems, Inc.; Quest Diagnostics,
Inc.; Lee BioSolutions; RayBiotech, Inc; Biocare Medical, LLC; and Abcam plc. Industry competition level is
expected to remain at moderately high level in the recent years Manufacturers are continuously introducing
technologically advanced products that will raise the competition in the market.
Market Segment:
Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 - 2022)
• Colorectal cancer
• Pancreatic cancer
• Ovarian cancer
• Breast cancer
• Thyroid cancer
• Others
Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• Spain
• Asia Pacific
• China
• Japan
• India
• MEA
• South Africa
• Latin America